A cost-benefit analysis of COVID-19 lockdowns in Australia.

This paper conducts a cost-benefit analysis of Australia's Covid-19 lockdown strategy relative to pursuit of a mitigation strategy in March 2020. The estimated additional deaths from a mitigation strategy are 11,500 to 40,000, implying a Cost per Quality Adjusted Life Year saved by locking down of at least 11 times the generally employed figure of $100,000 for health interventions in Australia. The lockdowns do not then seem to have been justified by reference to the standard benchmark. Consideration of the information available to the Australian government in March 2020 yields a similar ratio and therefore the same conclusion that lockdown was not warranted. If Australia experiences a new outbreak, and cannot contain it without resort to a nationwide lockdown, the death toll from adopting a mitigation strategy at this point would be even less than had it done so in March 2020, due to the vaccination campaign, lessons learned since March 2020, and because the period over which the virus would then inflict casualties would now be much less than the period from March 2020. This would favour a mitigation policy even more strongly than in March 2020. This approach of assessing the savings in quality adjusted life years and comparing them to a standard benchmark figure ensures that all quality adjusted life years saved by various health interventions are treated equally, which accords with the ethical principle of equity across people.

Introduction

As with most other countries, in early 2020 and in response to Covid-19, Australia’s federal and state governments implemented substantial general restrictions on mobility and economic activities involving the closure of non-essential businesses and confinement of the general public to their homes except for defined purposes (“lockdowns”). Since then, the restrictions have been substantially relaxed, but with temporary reinstatements in different parts of the country. This paper conducts a cost–benefit analysis (otherwise called a cost-effectiveness analysis) of this lockdown strategy relative to a milder strategy involving case isolation, quarantining of members of their households, limiting large gatherings, social distancing in public spaces, border controls, and restrictions targeted at only high-risk groups (“mitigation”). This alternative was selected because it was the most widely contemplated alternative to lockdowns and could be expected to involve significantly lower costs. The population of concern is that of Australia. The Covid-19 deaths estimated are those over the period until the end of 2021 (on the basis that mass vaccination will be completed by then and therefore any case for lockdowns will cease at that point). The costs examined are society-wide costs without limit on the time horizon over which they are incurred because they can extend beyond the point at which lockdowns cease (but constrained by the difficulties in estimating longer term costs).

The paper commences by examining the optimal decision in March 2020 using data available as at 28 June 2021. It then considers the optimal decision based on information available at the time of the initial lockdown decision. Finally, it considers the optimal course of action now if a new outbreak occurs that cannot be contained without resort to lockdowns.

The costs and benefits of lockdowns in March 2020

Deaths

The primary intended benefit of lockdowns is a reduction in deaths.1 The deaths attributed to Covid-19 under the adopted lockdown policy have been about 1000 to date.2 Much less clear is what the death toll would have been under a mitigation policy. In mid March 2020 the Australian government estimated that, without lockdowns, up to 60% of the population would be infected and 1% of these would die, leading to up to 150,000 deaths.3 Shortly afterwards, in late March 2020, Blakely and Wilson (2020) estimated deaths from an eradication (lockdown) policy at 5000, those from a mitigation strategy at 25,000–55,000, and a worst-case scenario of 134,000 arising from no mitigation measures and 60% of the population then being infected. Subsequent estimates by Bailey and West (2020), drawing upon analysis by Moss et al. (2020) using data to 31 March 2020, involved 27,000 deaths under eradication (lockdown), 141,000 deaths under mitigation, and 287,000 deaths with no mitigating actions. Subsequent estimates by Holden and Prescott (2020) involved the government “allowing enough people to get infected to result in herd immunity”, leading to 90% of the population being infected, and 1% of these dying, yielding 225,000 deaths. Subsequent estimates by Kompas et al. (2020, pp. 8–9) using data to 1 June 2020 involved 100 deaths from adoption of the suppression measures actually adopted, 35,000 if implementation had been delayed by 28 days, and 260,000 if no actions were taken by government or individuals. Blakely et al.’s (2020) estimates use mortality rates by age group from the Ferguson et al (2020) study in the UK. These in turn are based upon an epidemiological model in which each infected individual is estimated to infect R others (the reproduction rate) and this process extrapolated until so many people are infected that the virus dies out for lack of new targets. The estimates of Bailey and West (2020), derived from Moss et al. (2020), and those of Kompas et al. (2020), share this crucial feature.

Amongst these predictions, only those considering both mitigation and lockdown strategies are relevant: 20,000 to 50,000 additional deaths by Blakely and Wilson (2020), and 114,000 by Bailey and West (2020). However, in both of these models, the estimated deaths under lockdown (5000 and 27,000) are far in excess of the actual deaths incurred to date under lockdown, and this implies that their estimates of the additional deaths under mitigation will also be far too high. In addition, the death rate estimated by Bailey and West under a mitigation policy (141,000 deaths, which is 5500 per 1 million of Australia’s population of 26 m) is vastly in excess of the death rate per 1 million of population to date in any European country pursuing a mitigation policy or any alternative.4 In addition, both of these models do not allow for the fact that, as the number of deaths rises, people will react by engaging in more and more protective actions that will reduce the future death rate, such as hand washing, mask wearing, reducing social interactions, and working from home.

In view of these empirical and theoretical deficiencies, I estimate the additional deaths under a mitigation strategy rather than a lockdown strategy in Australia by examining the death rates in other countries. Foster (2020) uses the death rate in Sweden to estimate the additional Australian deaths under a mitigation approach at 10,000 (at the time of her analysis in August 2020). However, Sweden was not the only mitigator; Iceland, Finland and Latvia did likewise. Even better would be to use the full set of countries with reliable data. One such approach would be to conduct a cross-country regression of death rates on variables found to influence such death rates, and include amongst the explanatory variables the strength of government restrictions. The coefficient on this latter variable would then provide an estimate of how many extra deaths would arise if the restrictions were less onerous. Chaudhry et al. (2020) examines the 50 countries with the highest case counts as at 1 April 2020, and regresses cross-country death rates per 1 million of population (up to 1 May 2020) on a number of independent variables, including various measures of government intervention. They find that none of these latter variables were statistically significant. Gibson (2020) conducts a similar analysis, using the 34 OECD member countries, death rates up to 18 August 2020, and various independent variables including the average level of government restrictions over the period of the crisis.5 He finds that policy stringency (averaged over the whole crisis period) is not statistically significant in explaining cross-country variation in death rates (ibid, Table 2). He also examines average stringency both before and after the estimated infection peak for each country, and finds mild statistical significance for average stringency prior to the estimated infection peak along with a negative coefficient (ibid, Table 2). He also uses average stringency in other countries within the same OECD group as an instrumental variable, to test for reverse causality between stringency and death rates, and finds no evidence of reverse causality. Hale et al. (2020b) conduct a similar analysis, using 170 countries and data to 27 May 2020. They find that both the speed of government response (number of days from the first reported case till the government restrictions reach 40 on the Hale et al. 2020a Stringency index) and the severity of the restrictions (using the Stringency index of Hale et al. 2020a) affect death rates in the expected way. Argarwal et al. (2021) examine excess deaths (actual less those predicted using pre-pandemic data) in 43 countries and all 50 US states following Shelter-in-Place orders, and find that excess deaths do not decline following such orders, except for all of the island nations and states in their data set (which include Australia).

Table 2

GDP forecasts

	19–20	20–21	21–22	22–23	23–24	24–25	Sum
Dec 2019 Forecasts	2.25%	2.75%	3.0%	3.0%	3.0%	3.0%
Implied GDP	102.3	105.1	108.2	111.5	114.8	118.2
June 2021 Forecasts	− 0.2%	1.25%	4.25%	2.5%	2.25%	2.5%
Implied GDP	99.8	101.0	105.3	108.0	110.4	113.2
Shortfall	2.5	4.1	2.9	3.5	4.4	5.0	22.4

Given the actual or probable unreliability of data from many countries, it is desirable to limit the analysis to countries for which the data is likely to be very reliable. It is also desirable to eliminate countries with federal systems, in which restrictions varied by state or province, because the Hale et al. (2020a) data is only available at the country-level. This leaves European countries and the East Asian democracies (Japan, South Korea, Taiwan, Singapore, plus Hong Kong). Hale et al. (2020a) have constructed a set of indexes, which assign a daily score to each country for the severity of their restrictions imposed by government, ranging from 0 to 100 and taking account of different types of restrictions. I use their Stringency Index, which takes account of 8 different types of government restrictions.6 Death rates per 1 million of population are drawn from https://www.worldometers.info/coronavirus/. All five East Asian countries have very low death rates regardless of the severity of restrictions, and the possible reasons (a culture of mask wearing, not shaking hands, compliance with government directives, extensive contact tracing and testing, and pre-existing immunity) are or were not applicable to the same degree in Australia. So, I use only the European countries, of which there are 33.7 They are similar (on average) to Australia in ethnicity, cultural norms, demographics, GDP per capita, and the quality of their health care systems. By contrast, they have generally colder temperatures and a smaller proportion of their populations from East Asia (thereby benefiting less from any pre-existing immunity amongst East Asians).

In using the Stringency Index, there is a choice of the average and maximum values, and both have merits. The maximum reflects only government policy on one day whilst the average (crudely) takes account of it over the entire period of the crisis. However, a given average value could arise from a wide range of different policies. An extreme case of this would arise if one country adopted its maximum stringency index value of 100 on the first day, retained it for 6 weeks and then removed all restrictions because eradication had been achieved, whilst a second country maintained a stringency index value of 50 throughout the 12 weeks of the analysis. Both would have an average Stringency of 50, but would have adopted entirely different policies. I therefore use both the average and maximum values.

Death rates are likely to be affected by many variables other than the severity of government restrictions, and it is desirable to include them. I consider Mass vaccination commenced in Europe in December 2020. Since the speed of vaccination is likely to be a significant explanatory variable from that point, I conduct the analysis described above using data only to 30 December 2020. The first two variables are statistically significant, and substantially raise the adjusted , whilst the last eight variables (added and tested separately) are not statistically significant and their inclusion each lowers the adjusted . I therefore retain only the first two variables. Regressing the death rate per 1 million of population (D) up to 30 December on the maximum Stringency Index value (S), the population density (PD, in millions per 1000 square miles), and date of first death (FD, in days from 15 February) yields the following result:

Population density (higher values increase the transmission rate of the virus),

The date of the first death (in days after the first recorded death on 15 February in France), because later dates provide more time for people, doctors and their governments to learn from others and adjust their behavior,8

Population (higher values provide a higher pool of virus targets before restrictions on movements across national borders limit the movement of people and therefore the transmission of the virus),

GDP per capita (as a proxy for the quality of the health care system),

The population proportion over 65 (higher values imply a larger proportion of the population in the high risk group),

The average household size (higher values increase the pool of virus targets before restrictions on movements across households limits interactions and therefore the transmission of the virus),

The number of nursing and elderly home beds per 100,000 of population (because higher values implies a higher concentration in the high-risk group, which increases or lowers the death rate depending upon the effectiveness of the quarantine and other procedures),

The proportion of the adult population who are obese,

Average temperature, and

Influenza intensity in the last two influenza seasons.9

The is 0.29, and the p values are 0.66, 0.27, 0.10 and 0.10 respectively. The coefficient on S is statistically insignificant and the sign on it is ‘wrong’ (positive rather than negative).10 Even using the lower bound on the 95% CI for S of − 6.05, the expected increase in a country’s death toll from moving from the most restrictive policy (Bosnia with S = 100) to the least restrictive policy (Iceland with S = 54) would be to raise its death rate by only 6.05*(100 − 54) = 278 per 1 m of population. So, the evidence for government restrictions substantially reducing the death rate is minimal in general.

This result may seem counterintuitive, but explanations are available. One possibility is that reverse causality applies, i.e., the choice of policy is influenced by the death rate as well as the death rate being affected by the policy choice. The Appendix investigates this possibility and concludes that it does not operate. A second possibility is that, even without government restrictions, people will take actions to lower their risks in a pandemic and the incremental effect of government actions may then be too little to be statistically significant. A third possibility is that lockdowns will in some cases increase the risk of transmission to high-risk individuals, and this at least partly offsets the reduction in risks achieved in other ways. For example, lockdowns will have caused some young people to return to live with their older parents, perhaps because of the loss of their job or closure of the university they were attending, and if already infected to thereby infect their parents, who are at much greater risk of death. A fourth possibility is that some of the European lockdowns were not instituted quickly enough to be effective, and all of those that were instituted quickly enough were relaxed before elimination had been achieved (because their land borders were too porous to achieve elimination) leading to a resurgence in cases when the lockdowns were relaxed.

Nothing in the analysis so far precludes the possibility that some of these European countries experienced a lower death rate as a result of lockdowns, and the last point offers an explanation for that outcome: being an island and instituting the lockdown quickly. To assess whether Australia was in this category, I proceed as follows. The European data consists of countries that adopted mitigation strategies, and those that adopted lockdown strategies that in general performed no better or worse in their death rate. It follows that the European data are equivalent to that from a set of countries that in general pursued mitigation. So, an estimate of the Australian death rate under mitigation would be the average European death rate (680 per 1 million of population as at 30 December), corrected for differences in variables that are statistically significant in explaining the death rate. For Europe, these are population density (PD) and date of first death (FD), and the resulting model using death rate data to 30 December is

The is 0.26 and the p values on the coefficients are 0.002, 0.09 and 0.09 respectively. Substitution of Australia’s values for the regressors, of PD = 0.009 and FD = 15, yields an estimated death rate D under mitigation of 699 per 1 million of population. This is significantly more than the death rate actually experienced by Australia over the same period (35 per 1 million of population), and therefore suggests that its lockdown policy did lower its death rate.

This analysis uses data from European countries, because the quality of the data is judged to be sufficient, and conservatively excludes East Asian democracies (with very low death rates regardless of government policy) because cultural norms etc. may differ significantly from Australia. The next best source of data appears to be that from the Americas, but with the exclusion of the US and Canada (because they are federal systems with variation in policy by state) and exclusion also of Cuba, Nicaragua and Venezuela (because authoritarian regimes are likely to deliberately understate deaths). Countries with less than 50,000 people are also excluded because death rates expressed per 1 million of population (as the data source does) are only then expressible in multiples of 20 or more. Across the countries for which both Hale et al. (2020a) provides the Stringency data and the www.worldometers.info website provides death rate data, there are 28 such countries: Brazil, Argentina, Colombia, Mexico, Peru, Chile, Ecuador, Bolivia, Panama, Dominican Republic, Costa Rica, Guatemala, Honduras, Paraguay, El Salvador, French Guyana, Jamaica, Haiti, Trinidad and Tobago, Suriname, Aruba, Guyana, Belize, Uruguay, Cayman Islands, Barbados, Bermuda, and Dominica. Unlike the European data, population density and date of first death are not statistically significant, but the following two regressors are statistically significant:

Population (higher values provide a higher pool of virus targets before restrictions on movements across national borders limit the movement of people and therefore the transmission of the virus),

Having no land borders with other countries (water barriers rather than land borders better restrict the flow of people and hence the virus into a country).

If the maximum Stringency index is added, it is not statistically significant and the estimated coefficient on it is positive rather than the expected negative. With P denoting population in millions and I denoting no land borders (1 if so and 0 otherwise), the model exclusive of S is thus:

The is a respectable 0.43, and the p values on the three coefficients are 0, 0.01 and 0.01 respectively. Substitution of Australia’s values for the regressors, of P = 26 and I = 1, yields an estimated death rate under mitigation of 211 per 1 million of population. This estimate uses data from only the Americas.

If the European and Americas data are pooled, P, I and date of first death (FD) are statistically significant at the 10% level, with all coefficients having the expected signs. Addition of S yields a coefficient that is not statistically significant, and with the wrong sign. The resulting model exclusive of S is thus:

The is a respectable 0.36, and the p values on the four coefficients are 0, 0.07, 0.02 and 0.02 respectively. Substitution of Australia’s values for the regressors, of P = 26, I = 1, and FD = 15, yields an estimated death rate under mitigation of 460 per 1 million of population. This estimate uses data from both Europe and the Americas.

Across these three models (2), (3) and (4), the estimated death rate for Australia under a mitigation policy is 211 to 699 per 1 million of population up to 30 December 2020. With 26 million people in Australia, this implies 5000–18,000 deaths in Australia up to 30 December had a mitigation policy been pursued. The estimate of 18,000 uses the best quality data (from Europe) but is likely to be too high because Australia is an island, and this reduces its death rate, but there are too few islands in the European data (only two) for the dummy variable “Island” to be statistically significant and therefore warrant inclusion in Eq. (2). Since Australia’s actual Covid-19 deaths to 30 December 2020 (35 per 1 million of population) were much less than even the lowest of these estimates using foreign data and accounting for exogenous factors that affect death rates, this suggests that Australia’s lockdowns did reduce its Covid-19 death toll. This is consistent with Argarwal et al.’s (2021) conclusion for Australia. I therefore proceed on this basis, and it gives the Australian lockdowns the benefit of the doubt.

These estimates presume that Covid-19 deaths are accurately recorded. However, some Covid-19 deaths may be mistakenly attributed to another cause, or deaths from other causes mistakenly attributed to Covid-19, with the latter error possible simply because most victims have co-morbidities. By analogy, if a person is shot in the heart and then the head, and then dies, the cause of death may not be the head shot. In addition, lockdowns discourage or prevents some people suffering from non Covid-19 conditions from seeking medical attention, leading to some deaths in lockdown countries that would not otherwise have occurred, and these should be included in the incremental deaths from lockdown. In addition, mitigation increases the load on hospitals, leading to more deaths from other causes (through lack of care) in mitigation countries, and these should be included in the incremental deaths from mitigation. An estimate of the Covid-19 deaths that accounts for all of these phenomena is the actual deaths in 2020 less the predicted number without Covid-19 (“Excess Deaths”). The Euromomo Network has done so and estimated the number of deaths across 18 European countries progressively through 2020, 2019 and 2018 relative to a prediction (“baseline”). The Excess Deaths for 2020 exhibit sharp increases in March–April and November–December, consistent with the pandemic. The Excess Deaths to 31 December relative to the baseline are 290,000 for 2020 (from 15 February when the first Covid-19 death occurred in any of these 18 countries), 70,000 for 2019 and 115,000 for 2018.11 By contrast, the deaths attributed to Covid-19 across these 18 countries (to 31 December) were 334,000.12 Thus, if the baseline were used, the Excess Deaths in 2020 would be 290,000 and this differs from the 334,000 deaths attributed to Covid-19 by 15%. However, the baseline is an imperfect prediction, as evidenced by the results for 2018 and 2019 (which would be zero if the predictions were accurate). This is simply a consequence of the fact that deaths in these countries in a typical year are about 3 million, so that the prediction error of 115,000 for 2018 is a small proportion.13 All of this suggests that the 334,000 deaths attributed to Covid-19 in these countries are approximately correct.

Turning now to further deaths from 30 December 2020, these are likely to be significantly influenced by the speed of vaccination. However, even if a model could be developed to quantify this, the speed with which Australia would have vaccinated had it followed a mitigation strategy is indeterminable (and likely to be much faster than the speed with which it is vaccinating under its lockdown policy). So, the best available estimate of the additional deaths in Australia from 30 December 2020 under a mitigation strategy would seem to be that arising from applying the average ratio for Europe. Over the period from 30 December 2020 to 28 June 2021, the European deaths are 95% of those to 30 December, and the rate of deaths fell sharply towards the end of the period. This suggests that deaths from 30 December 2020 until the end of 2021 (at which point mass vaccination is likely to have been largely completed) will not exceed 1.5 times those to 30 December 2020.14

Applying this ratio of 1.5 to Australia, with estimated deaths to 30 December 2020 under a mitigation strategy of 5000 to 18,000, yields 12,500 to 41,000 deaths to the end of 2021. By contrast, deaths to 28 June 2021 under a lockdown policy have been almost 1000. So, the extra deaths resulting from a mitigation policy rather than a lockdown policy are estimated to be 11,500 to 40,000. By contrast, Blakely and Wilson (2020) predicted an extra 20,000 to 50,000 deaths.

Quality adjusted life years

In assessing the merits of health interventions, the standard methodology amongst health economists is to multiply the expected lives saved from a health intervention by the average residual life span of the victims without intervention, to yield the “Life Years” saved by the intervention, followed by some discount if the quality of these life years saved would be less than that of a normal healthy person. The result is called the Quality Adjusted Life Years (QALY) saved by the intervention, which is then compared to a benchmark figure.

Kompas et al. (2020, p. 8) estimates the average residual life expectancy of the victims at 6.9 years, by comparison of the average age of the Australian victims (75.6) with the life expectancy of Australians at birth (82.5). Such an estimate does not recognize that the set of people who reach the age of 75.6 excludes those who have died at an earlier age and therefore this set will have an average residual life expectancy greater than 6.9 years. The corrected estimate will then be too high because it does not recognize that Covid-19 victims are unusually unwell relative to those of age 75.6 in general. Blakely and Wilson (2020) adopt an average residual life expectancy for the victims of 5 years, but provide no supporting evidence. Foster (2020) does likewise.

Analysis of European data supports this figure of 5 years. I illustrate this with Sweden, which adopted a mitigation policy and incurred the highest death rate amongst European countries that did so. The age distribution of the Covid-19 victims is shown in the first two columns of Table 1, and the residual life expectancy (RLE) of Swedish people in each such age group is shown in the third column. Using these data, the average residual life expectancy of Swedish people with the same age distribution as the Covid-19 victims is 10.9 years.15 However, the Covid-19 victims differ from Swedish people of the same age distribution in two very significant ways.

Table 1

Residual life expectancy of Swedish Covid-19 victims

Age group	Victims	RLE	RLE	RLE	RLE
0–9	2	79.55	79.55	79.55(0.7)	79.55(0.7)
20–29	10	60.25	60.25	60.25(0.7)	60.35(0.7)
30–39	19	50.5	50.5	50.5(0.7)	50.5(0.7)
40–49	45	40.8	40.8	40.8(0.7)	40.8(0.7)
50–59	164	31.3	31.3	31.3(0.7)	31.3(0.7)
60–69	406	22.4	22.4	22.4(0.7)	22.4(0.7)
70–79	1268 (22%)	14.3	14.3	14.3(0.7)	4.45
80–84	1219 (21%)	9.1	6.67	4.72	2.80
85 +	2747 (47%)	6.3	0.6	0.6	2.14
Average (years)		10.9	7.7	5.5	4.7

The first of these differences is that a large proportion of the victims were residents of nursing homes, whose average residual life expectancy without Covid-19 was very low and might be even lower than suggested by their ages. If so, conditioning on residency of a nursing home as well as age would reduce the average residual life expectancy of the victims. In respect of Sweden, Stern and Klein (2020, p. 5) estimate that 53% of the Covid-19 victims aged at least 70 were residents of nursing homes, and that their average residual life span without Covid-19 was only seven months (ibid, pp. 16–17). Conservatively treating this subset of victims as the oldest in Table 1, they represent the entire 85 + group (47%) plus additional victims in the 80–84 group constituting 6% of the entire set of victims (6/21 of that group). Replacing the residual life expectancy of these people by seven months (0.6 years), the average residual life expectancy calculated from the data in Table 1 would fall to 7.7 years as shown in the fourth column of Table 1.16 By contrast, if this nursing home group were spread through the 70 + groups in proportion to the size of these groups, 28% would be in the 85 + group, 13% in the 80–84 group, and 13% in the 70–79 group. Replacing the residual life expectancy of these people by 0.6 years, the average residual life expectancy calculated from the data in Table 1 would fall to 6.4 years.

The second unusual feature of these Covid-19 victims is that they were unusually unwell, even for their age; virtually all had at least one co-morbidity, which is presumably well in excess of the rate for the general population of the same age distribution.17 A common such ailment was type 2 diabetes. The NHS (2018, Fig. 8) provides estimates for the increase in mortality risk from this disease (relative to the general population) by age and sex. Averaging over these categories, the increase is about 50%. However the group of interest here excludes those in nursing homes, because the estimate for the residual life expectancy of these victims already reflects co-morbidities. This exclusion lowers the average age of the remaining victims, and suggests an increase in their mortality risk of about 80%. In addition, a person with a residual life expectancy of 10 years (the average for the Covid-19 victims) would have a current mortality risk of about 5% over the next year, growing at about 11% per year compounded18:

Raising this initial mortality risk by 80%, from 5 to 9%, along with the same growth rate of 11%, reduces the residual life expectancy from 9.52 to 6.68 years, i.e., a reduction of 30%. A similar percentage reduction applies to the average residual life expectancy of a group. As noted above, virtually all of the victims had at least one co-morbidity, and multiple co-morbidities would reduce the average residual life expectancy of a group by even more.

Allowing for this additional feature of the Covid-19 victims is simplified by the fact that virtually all Covid-19 victims had co-morbidities. So, the subset of Swedish victims from nursing homes have their residual life expectancy set as before at 0.6 years (which will also reflect their co-morbidities), and all others have their residual life expectancy reduced by (conservatively) 30%. The results are shown in the penultimate column of Table 1, with the nursing home group conservatively assumed (as before) to be the oldest, and the last column of Table 1, in which the nursing home group is spread throughout the 70 + groups in proportion to their sizes.19 The average residual life spans are 5.5 and 4.7 years respectively, and a good estimate would lie between these figures. So, starting with 10.9 years, the reduction is to 6.4–7.7 years to account for the nursing home group, and then to 4.7–5.5 years to additionally account for co-morbidities in the rest. This supports the estimate of Blakely and Wilson (2020) and Foster (2020), of 5 years.

The last step here is the discount to reflect the imperfect health of virtually all of these victims without Covid-19. Miles et al. (2020, p. 69) use 20% based on prevailing discounts for type 2 diabetes with and without additional problems. In particular, they cite Beaudet et al. (2020, Table 3), who favour a quality of life discount of 21% for Type 2 diabetes without complications, and substantial additional discounts for further problems including 9% for heart disease and 16% for stroke. These discounts in Beaudet et al. (2020) suggest that Miles et al.’s (2020) 20% discount for an average Covid-19 victim is low. Consistent with this, Briggs (2020, Fig. 3) uses a discount of about 30% for Covid-19 victims, based upon norms arising from survey data from Szende et al. (2014). Furthermore, a large proportion of the victims were residents of nursing homes, for which the quality of life discount could reasonably be even higher. I adopt a conservative estimate of the discount, of 20%.

Table 3

Employment forecasts

	19–20	20–21	21–22	22–23	23–24	24–25	Sum
Dec 2019 Forecasts	2.25%	2.75%	3.0%	3.0%	3.0%	3.0%
Implied Employment	102.3	105.1	108.2	111.5	114.8	118.2
May 2021 Forecasts	− 4.2%	6.5%	1.0%	1.0%	1.25%	1.25%
Implied Employment	95.8	102.0	103.0	104.1	105.4	106.7
Shortfall	6.5	3.1	5.2	7.4	9.4	11.5	43.1

A further step undertaken by Briggs (2020, Fig. 3) is to discount future QALY losses, and the reduction is substantial. Briggs does not disclose the discount rate used, but use of the yield on ten-year Australian government bonds (averaged over the period Feb 2020-Jan 2021, of 0.9%) reduces the result in Table 1 above from 4.7 to 3.9 years. Since this does not seem to be standard practice amongst health economists, I do not incorporate this additional adjustment.

In conclusion, the QALYs saved by the Australian government pursuing lockdown rather than mitigation are estimated at 11,500*5*0.8 = 46,000 to 40,000*5*0.8 = 160,000.

Expected GDP losses

Turning now to the costs of the lockdown policy, I commence with the lost GDP because it is most amenable to quantification. Shortly before the pandemic arose, in December 2019, the Australian Treasury (2019, Table 1.2) forecasted Australia’s real GDP growth rates for 2019–2020 till 2022–2023 at the rates shown in the first row of Table 1.20 This is an estimate of growth in the absence of the pandemic. Arbitrarily designating 2018–2019 GDP as 100, the GDP results under this path are shown in the next row of the table. In May 2021 they released updates as shown in the third row of the table (Australian Treasury 2021, Table 1.2), with the implied GDP path in the fourth row. The last row of the table shows the difference between the two paths, which aggregates to 22.4, i.e., 22.4% of Australia’s 2018–2019 GDP. Since Australia’s 2018–2019 GDP was $1950b, this is $437b.21 This estimate is conservative because the two real GDP forecast paths in Table 2 have not converged over the period for which the forecasts are available (out to mid 2025). By comparison, Pujol (2020, Table 1) reports estimates of this type from nine advanced economies that locked down, using data from Consensus Economics, and the median loss is 25%. In addition, Gomez-Pineda (2020, Fig. 1) graphically presents annual estimates of this type for both advanced and developing economies (each averaged), and the accumulated losses over the 2020–2024 period are 25% and 40% respectively. Consistent with not discounting the QALYs, the GDP costs are also not discounted.

Some of these GDP losses of $437b would have arisen without any Australian government-imposed lockdowns, because some people would have reduced their interactions with others anyway; for example, a foreigner electing not to make a trip to Australia that they would otherwise have made, or an Australian choosing to avoid cafes. Further losses would have arisen due to the additional actions of foreign governments; for example, foreign governments preventing or discouraging their citizens from making foreign trips. Further losses would have arisen if the Australian government had followed merely a mitigation strategy, which includes border closures. Finally, further losses would have arisen from the Australian government instead following a lockdown strategy. It is only the last category of these losses that can be attributed to the Australian government choosing a lockdown policy rather than a mitigation policy.

Estimating the proportion arising from this last category is difficult. Andersen et al (2020) examine the drop in consumer spending in the early stages of the pandemic in both Denmark (which adopted a lockdown policy) and Sweden (which adopted a mitigation policy). They find that the drop in Sweden was 86% of that in Denmark (25% drop vs 29% drop), implying that 14% of the drop in Denmark was due to a lockdown rather than a mitigation policy. In a similar study (Goolsbee and Syverson 2020) examine adjoining US counties with one area subject to lockdown and the other not; the drop in consumer activity in the latter area was 88% of the former, implying that only 12% was due to the lockdown. Doti (2021, p. 120) conducts a cross-sectional study of all US states and concludes that 75% of the GDP losses were due to state government level interventions (from a Stringency Index of zero to the state average of 42), i.e., 2.2% out of 3%. Since the latter variation in the Stringency Index values approximates the difference between mitigation and extreme rather than an average lockdown, this suggests that an average lockdown would explain 1.1%/1.9% = 57% of the GDP loss. Aum et al. (2020) estimate the effect of increased infections upon the unemployment rate in Korea (which did not lock down), the US and UK (which did), and conclude that the effect is twice as great in the US and UK, leading to the conclusion that lockdowns explain 50% of the loss of employment. In a much broader study, the IMF (2020, Chapter 2) examined 28 countries and concluded that lockdowns contributed 40% of the reduction in ‘Google Mobility Data’ in advanced economies, which is a proxy for the GDP loss. In a similar study, Caselli et al. (2021) found that the reduction was 44% using the same data source (ibid, Fig. 4) and also 44% using job postings data (ibid, Fig. 5), all for advanced economies. In an approach directly comparable with Table 2 above, Pujol (2020, Table 2) presents estimates of the GDP losses for nine advanced economies that locked down (US, Canada and seven Western European economies), and two that did not (Sweden and Japan); the median of the first group is 25% and that of the latter is 16%, which implies that 36% of the loss is due to lockdowns.

In summary, these estimates of the proportion of GDP losses due to an average lockdown relative to mitigation range from 12 to 57%. The best estimates here are the last three (40%, 36% and 44%), because they each cover a wide range of countries. I adopt the median estimate of 40%. Applying it to the Australian GDP loss of $437b yields a loss due to the lockdowns of at least $175b.

Amongst other Australian analyses, Foster (2020) and Holden and Prescott (2020) also estimate the GDP losses by reference to forecast growth rates, but do not accumulate the losses over the entire period of the shortfall. By contrast, Kompas et al. (2020, pp. 11–14) estimates the GDP losses for each day of the lockdown, scales this up for 8 weeks of lockdown (56 days) to yield $52b, and then assumes a four month transition path back to “normal”, yielding a GDP loss of up to $120b. However, the Australian Treasury could reasonably be presumed to have far greater expertise in predicting GDP (see Table 2 above). Some analyses assess costs and benefits only during the period of lockdown, which is equivalent to (implausibly) assuming that GDP immediately reverts to the pre-pandemic forecast path upon cessation of the lockdown (for example, Scherbina 2021, Fig. 4).

Cost per QALY saved

In summary, the QALYs saved by locking down rather than mitigating are estimated at 46,000 to 160,000 whilst the associated GDP losses are expected to be at least $175b. If these GDP losses were the only cost of lockdowns, the cost per QALY saved would then be at least $1.09 m as follows:

I now attempt to quantify all of the additional costs of mitigation. Firstly, there are the medical costs of those requiring short-term hospitalization under a mitigation policy. Gros (2020, Sect. 2.2) assumes that the entire population of a country becomes infected, and estimates that 20% would require general hospital care at a cost per patient equal to 30% of GDP per capita, and 25% of these would also require Intensive Care treatment at a further cost per patient of 60% of per capita GDP, yielding a total cost equal to 9% of GDP. However the assumption that everyone in a population would become infected is excessive. Blakely and Wilson (2020) estimate that the infection rate would not exceed 60% because the epidemic would by then peter out through herd immunity, Boyd (2020, p. 3) adopts a base case of 40% based upon the experience from past pandemics, and Aguas and Corder (2020) estimate it to be even lower.22 Furthermore, even if Gros’s estimates of the proportion infected requiring medical care were correct, this would (even at a 40% infection rate) imply 2 m Australians requiring hospitalization (8% of its population), and 500,000 of these requiring an ICU. However, there would not be enough hospital beds or ICUs in the country or medical staff to cater for even a fraction of them.

By contrast, Bailey and West (2020, Appendix A) estimate hospitalized cases at 960,000, ICU cases as 256,000, and deaths at 141,000 under a mitigation policy. Since my upper bound on the number of deaths under a mitigation policy is 41,000, this implies 280,000 hospitalised cases and 74,000 ICU cases. Clearly, the Australian hospital system could not accommodate all of them. Furthermore, whatever number of cases were accommodated, they would be to some degree permanently displacing other types of patients so the incremental costs would be even less. Even without displacement, most of the medical costs would be fixed (staff, buildings, and equipment) and therefore irrelevant. The upper limit on the costs arises if the system could accommodate all cases, there is no displacement of other types of patients, and all costs are variable. Using Gros’s costs of 60% of GDP per capita for ICU cases and 30% for the rest along with Australia’s GDP per capita of $75,000, the upper bound on the resulting incremental costs would be $9.6b as follows:

Kompas et al (2020, Sect. 4.3) estimates the costs at $23.3b under their no suppression scenario, which involves 260,000 deaths. Scaled down to reflect the 41,000 deaths forecasted here under a mitigation scenario, the result is $3.7b. Using the higher figure of $9.6b to modify Eq. (5), the cost per QALY is now $1.03 m as follows:

Secondly, mitigation gives rise to some survivors who may experience significant long-term adverse consequences. Arnold and Hamilton (2020) report that, amongst Covid-19 cases in the UK who were hospitalized, 26% died and 74% of the rest had ongoing problems after 12 weeks, implying a ratio of slow recovery patients to dead of 74*0.74/26 = 2.1. However, this ratio will be too low because it excludes slow recovery patients who were never hospitalized. Using data from the Covid Symptom Study, Couzin-Frankel (2020) estimates that 10–15% of all of those infected do not recover quickly. More recently, and using the same data source, Greenhalgh and Knight (2020) estimate that 10% of those who have tested positive remain unwell after three weeks and a smaller (but unquantified) proportion for months. More recently, in October, and using the same data source, Sudre et al. (2020) estimate that 13.3% of those who tested positive remained unwell for at least four weeks, with 8.8% resolved in 4–8 weeks, a further 2.2% resolved in 8–12 weeks, and the remaining 2.3% unresolved after 12 weeks. A pattern consistent with this data is that, amongst this group who are still unwell after 4 weeks, 68% experience symptoms for 4–8 weeks, 16% for 8–12 weeks, 8% for 12–16 weeks, etc. The average time unwell is then

This series can be decomposed into a set of geometric progressions and then added, to yield an average of 9 weeks (0.16 years). As of 15 October 2020, there were 38.6 m recorded cases and 1.1 m deaths worldwide. So, the ratio of these long-recovery Covid-19 cases to deaths is 38.6 m*0.133/1.1 m = 4.7. Furthermore, consistent with the figure used earlier for Covid-19 victims suffering from serious pre-existing conditions, their quality of life is thereby initially reduced by 20%. Allowing for all this is then equivalent to increasing the QALYs saved from lockdown rather than mitigation by 4% as follows:

This raises the denominator in Eq. (6) by a factor of 1.04. There will also be medical costs associated with these very long-term sufferers. For example, if each such person’s medical costs average $10,000 per year in which symptoms are experienced, the cost for 193,000 survivors (41,000 victims*4.7) for 0.16 years on average is $313 m. Both the denominator adjustment of 1.04 and the numerator addition of $313 m are too small to warrant inclusion, and alternative (reasonable) assumptions about the time profile of the resolution of these cases and the cost per year per patient do not change this conclusion.

Thirdly, mitigation gives rise to work absences amongst those who are infected and must self-isolate. Gros (2020, Sect. 2.1) assumes all members of a population are infected, 30% require a work absence of four weeks and a further 20% require six weeks, leading to a GDP loss of 5% of one year’s GDP:

However the assumption that everyone in a population would become infected is excessive. As noted previously, Blakely and Wilson (2020) estimate that the infection rate would not exceed 60% because the epidemic would by then peter out through herd immunity, Boyd (2020, p. 3) adopts a base case of 40% based upon past pandemics, and Aguas and Corder (2020) estimates an even lower rate. Furthermore, even if Gros’s estimate of 50% of those infected requiring a work absence were correct, this does not yield a proportionate decline in GDP for various reasons. In particular, many of the people required to isolate could still perform their work from home. Furthermore, even where those isolated could not thereby perform their tasks for this period of weeks, other employees of the organization would increase their productivity or hours of work to at least partly compensate, and/or customers of the businesses would experience longer wait times with no loss of output, and/or the absent employees would be able to perform at least some of the work upon their return in addition to their normal workloads. Accordingly, a more reasonable estimate of the GDP loss than Gros’s would involve 40% of the population being infected, and 30% of those requiring isolation able to still perform their jobs at home, and 75% of the rest having their work performed by others or by them upon their return to work or addressed through longer customer queues. The resulting GDP loss would then be only 5%*0.4*0.7*0.25 = 0.35% rather than 5% of one year’s GDP. In dollar terms this is $1950b*0.0035 = $6.8b. Modifying Eq. (6), the cost per QALY saved would be at least $990,000 as follows:

This figure is too low for three principal reasons. Firstly, the estimate of 160,000 QALYs saved by locking down is likely to be too high because it uses the highest estimate of additional deaths from locking down (from the European data). Secondly, the estimate of $175b for the GDP losses from the lockdowns is too low because the two real GDP forecast paths in Table 2 have not converged over the period for which the forecasts are available (out to mid 2025).

Thirdly, no allowance has been made for various phenomena that would raise the costs of lockdowns but cannot readily be quantified: problems arising from the increased unemployment (addiction, crime, domestic violence, mental health problems, and premature death), loss of social interactions, increased anxiety, disruption to the education of the Covid-19 student cohort, and the deprival of liberties that people would otherwise enjoy. Lockdowns also disrupt the normal operation of the health care system, leading to deaths that would not otherwise occur (such as people who fail to have cancer screening tests done), but failure to lockdown would also likely saturate the system with Covid-19 cases, leading to deaths amongst other types of patients who have been crowded out. The net effect of this point is very unclear, because it depends inter alia on how quickly a society could expand its health care system to accommodate the increased caseload, but the net short-term effect is likely to be small because the deaths attributed to Covid-19 approximate the excess deaths relative to pre-pandemic forecasts (as discussed in Sect. 2.1).

Foster (2020) attempts to quantify the adverse psychological impact of lockdowns on the average Australian, and concludes that it dominates all other considerations. The estimates are inherently subjective. Nevertheless, I consider the psychological effect of unemployment on the unemployed during the period of unemployment because the numbers of people affected can be estimated. Table 3 shows forecast growth rates for the Labour Force in December 2019 (Australian Treasury (2019, Table 1.2) and in May 2021 (Australian Treasury, 2021, Table 1.2).23 Arbitrarily designating the 2018–19 Labour Force as 100, the Labour Force results are shown under each forecast path, and the shortfall for each year shown in the last row, which aggregates to 43.1, i.e., 43.1% of Australia’s 2018–2019 Labour Force. Since Australia’s 2018–2019 Labour Force was 12.9 m, this is the equivalent of 5.6 m unemployed for one year.24 This estimate is conservative because the two Labour Force forecast paths in Table 3 have not converged over the period for which the forecasts are available (out to mid 2025).

Some of these Labour Force shortfalls would have arisen from the pandemic without any lockdowns, and it is only the fraction due to the lockdowns that are of interest. Section 2.3 estimates the proportion of the GDP shortfalls due to lockdowns at 40%, and the same proportion is applied here. So, lockdowns are expected to have reduced the size of the Labour Force by the equivalent of 5.6 m*0.40 = 2.2 m for one year, i.e., 2.2 m people losing their jobs for one year. Frijters (2020) estimates that the loss of employment for one year reduces a person’s quality of life during that year by the equivalent of 0.12 years of life.25 This estimate is subjective, but so too is the estimate of the reduction in life quality of a typical Covid-19 victim by 20% to reflect their co-morbidities (in Sect. 2.2 above). In the interests of being very conservative, I halve Fritjers estimate of 0.12 years of life. So, the loss of employment for 2.2 m people for one year is equivalent to the loss of 2.2 m*0.06 = 130,000 QALYs. Netting this off against the 160,000 QALYs saved by the lockdown (at most), and modifying Eq. (7), the cost per QALY saved would be at least $5.3 m as follows:

The benchmark valuation of a QALY

In respect of Australia, Blakely and Wilson (2020) use a benchmark of $100,000 per QALY saved, based upon “rules of thumb in the Australian health system”. Foster (2020) uses the same figure. By contrast, the WHO recommends a benchmark equal to a country’s per capita GDP (Bertram et al. 2016), which is currently $75,000.26 Interestingly, Blakely and Wilson also co-authored an almost identical paper for New Zealand (Blakely, Baker and Wilson 2020), and they adopted a benchmark figure of GDP per capita in that case. In other recent health interventions in Australia, Cheng et al. (2016) used $50,000 in assessing cardiac rehabilitation programs as does Kularatna et al. (2020, p. 5) in assessing oral health interventions. Using survey evidence on willingness to pay, Huang et al. (2018) estimate the value at $22,000–$67,000 while Lewkowski et al. (2020) estimate it at $100,000 for men and $50,000 for women. In the interests of being conservative, I favour the largest figure here of $100,000.

A related concept is the “Value of a Statistical Life” (VSL), which values all lost years of an average aged person’s life. This is recommended in decisions on reducing physical harm, such as in traffic safety and occupational safety, and the current value is $4.9 m (Office of Best Practice Regulation 2019, p. 2). This figure is derived from Abelson (2008), who recommends use of its annual equivalent (the Value of a Life Year or VLY: ibid, p. 16), which is performed for a person with a 40-year residual life span using a discount rate of 3% (ibid, p. 3). Abelson’s (2008) use of a 40-year residual life span presumably arose from it representing half of the life expectancy of an Australian (at birth) at that time. This life expectancy is now 41.4 years.27 Furthermore, Abelson’s discount rate of 3% presumably reflected market discount rates at that time. These are now considerably lower. In respect of New Zealand, Pharmac (2015, pp. 51–52) recommended that all costs and benefits in health expenditure assessments be discounted by 3.5% per year, based on the five-year average real government bond rate. Following this, I use the average yield on ten-year inflation-indexed Australian government bonds over the last five years (January 2016 to December 2020), of 0.75%.28 Applying this discount rate of 0.75%, the VLY would be such that

The solution is VLY = $141,000. By contrast, the Office of Best Practice Regulation (2019, p. 2) recommends $213,000, derived using a 40-year period and a discount rate of 3%. Kompas et al. (2020) uses this latter figure. In choosing between a VLY and the value of a QALY, Gros (2020, p. 6) favours the latter because it is the approach that is “practiced routinely by the medical profession” whilst Miles et al. (2020, p. 76) also favours it because it is consistent with the approach to other health expenditures. I concur and therefore favour a QALY value of $100,000.

Interestingly, some analyses of the Covid-19 issue have been conducted by simply coupling the VSL by the expected number of lives saved rather than coupling the value of a QALY or a VLY with the expected number of (quality adjusted) life years saved (for example, Chapple 2020; Thunstrom et al. 2020; Holden and Preston 2020). This may reflect a belief that Covid-19 victims have a typical average residual life span and perfect health without Covid-19, which may be true in safety interventions but is not the case here, and would therefore significantly overestimate the benefits in QALYs saved. Alternatively, it may reflect their ethical belief that all lives saved are equally valuable, which implies that one would spend as much to extend the life of a person by one day (or even one hour) as one would spend to extend the life of a different person for fifty years. If the latter interpretation is correct, it would be perverse to do so. It would also be inconsistent with prevailing views amongst public health experts in Australia and elsewhere, in which the impact of health interventions on the residual life expectancy of the targets is estimated and converted to a monetary figure using a value per year (Bertram et al. 2016; Cheng et al. 2016; Blakely and Wilson 2020).

Comparison of cost with benchmark

In summary, the cost per QALY saved is at least $990,000 if the psychological effects of unemployment are ignored and at least $5.3 m if these latter effects are recognized, as shown in Eqs. (7) and (8). Since the benchmark figure is $100,000 then the cost per QALY saved significantly exceeds this benchmark figure of $100,000, and therefore the March 2020 lockdowns were not justified by the standard methodology. This conclusion is strengthened by numerous additional considerations. Firstly, substituting Blakely and Wilson’s (2020) higher estimate of the additional deaths from mitigation (up to 50,000) for the additional 40,000 deaths underlying Eq. (7) does not change the conclusion. Secondly, substituting Bailey and West’s (2020) even higher estimate of the additional deaths from mitigation (114,000) for the additional 40,000 deaths underlying Eq. (7) does not change the conclusion. Thirdly, many of the parameter estimates in Eqs. (7) and (8) are towards the end of their probability distributions that yield the lowest possible cost per QALY, most particularly the 160,000 extra QALYs lost from mitigation (likely to be too high) and the $175b GDP loss due to lockdown rather than mitigation (likely to be too low). Fourthly, apart from the allowance within Eq. (8) for the contemporaneous effect on the unemployed from losing their jobs, no allowance has been made for various phenomena that would raise the costs of lockdowns but cannot readily be quantified: more tangible problems arising from increased unemployment (addiction, crime, domestic violence, mental health problems, and premature death), the loss of social interactions, increased anxiety, disruption to the education of the Covid-19 student cohort, and the deprival of liberties that people would otherwise enjoy.

The conclusion here might seem to result from the mechanistic application of an economic rule, devoid of ethical considerations. However, consistent application of this rule is necessary to ensure that all quality adjusted life years are treated equally, which in turn derives from the ethical principle of equal treatment of people (appropriately adjusted for differences in their residual life expectancy and the quality of those years).

The merits of lockdown versus mitigation using data available in March 2020

I now consider the merits of the lockdown decision using data available in March 2020. I focus upon Eq. (7), which does not include the effects of unemployment. The denominator there must be replaced by an estimate derived from contemporaneous data. In mid March 2020, the Australian government believed that the death toll without lockdown would be 50,000 to 150,000, arising from 20 to 60% of the population being infected and an Infection Fatality Rate of 1% (see p. 2). A few days later, Blakely and Wilson (2020) estimated the death toll under lockdown at 5000 if successful, that under mitigation at 25,000 to 55,000, and 134,000 dead arising from an infection rate of 60% of the population if no mitigating actions were taken by the government. This suggests that the Australian government’s worst case of 150,000 dead assumed no mitigating actions, and therefore the best estimates in March 2020 of the death tolls under mitigation and lockdown were 40,000 (the midpoint of 25,000 and 55,000) and 5000 respectively. Assuming lockdown was bound to be successful, this implies (40,000–5000)*5*0.8 = 140,000 QALYs saved by locking down. The medical costs in the numerator of Eq. (7) must also be raised to be consistent with the revised denominator value. Kompas et al. (2020, Sect. 4.3) estimates them at $23.3b under a worst-case death toll of 260,000. Scaled to reflect 35,000 additional deaths rather than their worst case, these costs fall to $3.1b.

In addition, GDP forecasts are required for March 2020 and from the same source just before the pandemic struck. The Australian Treasury provides forecasts only six monthly, in July and December. By contrast, the RBA provides forecasts every 3 months, and the relevant ones are for November 2019, February 2020 and May 2020. The first of these predates the pandemic, the second recognizes some Australian GDP losses from the pandemic but only due to the spillover from its impact on China (RBA 2020a, Chapter 5), whilst the third fully recognizes the effect of the pandemic on Australia (RBA 2020b, Chapter 6). I use the May 2020 forecasts as a proxy for views in March, along with the November 2019 forecasts. For the years ended June 2020, 2021 and 2022, the November 2019 forecasts are 2.5%, 3% and 3% (RBA 2019, Table 5.1), whilst the May 2020 forecasts for the same years are − 8%, 7% and 5% respectively (RBA 2020b, Table 6.1).29 Using these to estimate the GDP shortfall in the same way as Table 2, the result is a shortfall of 21.5% of 2019 GDP. Since Australia’s 2018–2019 GDP was $1950b, this is $420b.30 I attribute 40% of this to the lockdown, as in Sect. 2.3, to yield $168b. This estimate is conservative because the two real GDP forecast paths here have not converged over the period for which the forecasts are available (out to mid 2022). Substitution of these parameter values into Eq. (7) yields a cost per QALY saved of $1.1 m as follows:

So, the cost per QALY saved is 11 times the benchmark value of $100,000. This strongly favoured mitigation in March 2020. Allowing for the possibility that the lockdowns would fail (Blakely and Wilson 2020, ascribed a 75% probability to this), the cost per QALY saved would be even higher and therefore mitigation would be even more strongly favoured. For example, if the probability of the lockdowns failing were 50%, the expected death toll from the lockdowns would be 5000*0.5 + 40,000*0.5 = 22,500, implying an expected saving in lives from the lockdowns rather than mitigation of 40,000 − 22,500 = 17,500, which implies 17,500*5*0.8 = 70,000 QALYs saved by the lockdowns. This halves the denominator in the last equation, which doubles the cost per expected QALY saved to $2.2 m.

This leaves the question of why the Australian government chose to undertake lockdowns in March 2020. A natural candidate for explaining this is that it was extremely risk averse, i.e., it focused upon the worst case death toll from mitigation over lockdown, of 150,000–5000, which implies 580,000 QALYs saved by locking down. Substituting this into the denominator of the last equation, and scaling up the medical costs consistent with this incremental death toll of 145,000 (from $3.1b to $13.0b), the cost per QALY falls to $250,000:

Even this is above the benchmark of $100,000. So, even extreme risk-aversion does not fully explain the government’s decision to undertake lockdowns.

A complementary possibility is that the Australian government was also prepared to pay more than the worst-case scenario just described (at the conventional price of $100,000 per QALY saved) to buy ‘peace of mind’ insurance for the whole population. Assuming that lockdowns would succeed, the additional payment would be P satisfying the following equation:

The solution is P = $90b, i.e., the Australian government was prepared to pay $90b in addition to the payment consistent with applying the usual QALY benchmark to the worst case death toll scenario under mitigation coupled with lockdowns being successful. Doing this is not consistent with standard methodology in assessing health interventions, and therefore with the ethical principle of equity. Furthermore, peace of mind benefits are not unique to pandemics, as virtually all health or safety interventions increase peace of mind for the whole population as well as saving QALYs. For example, the road toll in Australia is currently about 1200 per year, and peaked at 3800 in 1970.31 This reduction has come in part through road safety expenditures, which have reduced deaths and therefore increased the peace of mind of every motorist (who is at risk of becoming the next victim). Furthermore, the number of QALYs saved here is at least as great as those from pandemic lockdowns, because pandemics for which lockdowns would be contemplated are very rare. If they arise every (say) 50 years, it is necessary to compare them with savings from road safety measures over 50 years. If such measures save 1000 lives per year, with an average residual life expectancy for the victims of 40 years and perfect health, they save 1000*40*50 = 2 m QALYs over 50 years. This is much more than even the worst case scenario for Covid-19 of 580,000 QALYs saved. Despite this, road safety measures are evaluated purely on the basis of the value of the QALYs saved and not also because they increase peace of mind for the entire population.

In seeking an explanation for the decision to lock down, it is noteworthy that the situation is characterized by several highly unusual features in health and safety interventions. Firstly, the source of the problem was new; the resulting absence of directly relevant historical experience may have led decision makers to fear worst case scenarios beyond even those articulated by expert opinion. Secondly, since the effectiveness of lockdowns could reasonably be expected to fall away quickly with any delay, a decision was required much more quickly than the speed at which governments normally operate and haste generally reduces the quality of decision making. Thirdly, the death toll from failure to lock down would be more highly concentrated in time than most other health and safety interventions, which would exaggerate the emotional perception of the death toll and concentrate responsibility for it upon the decision makers, especially since the media gave Covid-19 deaths such attention. Fourthly, the cost of locking down (primarily in the form of GDP losses) would be distributed over several years and therefore would not be attributed entirely to the decision makers. Finally, the unusual form of the most visible cost (GDP losses) lacks the emotional resonance from the more usual monetary payments, and therefore focused decision makers upon the benefits from lockdowns rather than the costs as well as the benefits. The confluence of these factors may have induced the decision to undertake lockdowns, contrary to standard principles of cost–benefit analysis even when using the worst case scenarios articulated by expert opinion.

Looking forward on 5 July 2021

The analysis to date examines the possibility that mitigation was adopted by Australia in March 2020. Since then, there have been further but more localized lockdowns, and further instances are possible. Assessing the merits of any future lockdowns requires (as before) an estimate of the deaths that would be experienced under a mitigation policy. Such an estimate will be much less than that provided in the previous sections, even if the lockdown covered the same area and was for the same duration, for three reasons. Firstly, the period over which the virus could then inflict casualties would be much less, i.e., from the point in time at which it erupts (after 28 June 2021) until mass vaccination (of high-risk groups) is completed in several months, rather than from March 2020 until this mass vaccination point. Secondly, the vaccination campaign to date and over the period until mass vaccination is achieved will further reduce the death toll. Thirdly, policy and medical lessons have been learned since the first lockdowns that will further reduce deaths if a mitigation policy is adopted, such as the importance of quarantining rest homes, the best use of ventilators, the importance of prone positioning, and improvements in contact tracing and testing. In addition, the GDP losses from such a lockdown will be less than the lockdowns commencing in March 2020 ($175b), but the reduction should be less pronounced than for the deaths because GDP losses are strongly tilted towards the lockdown period whilst the lives saved by lockdowns are more evenly spread over time until the mass vaccination point.

To illustrate these points, suppose that mass vaccination of high-risk groups will be completed at the end of 2021. Suppose further that a new outbreak occurs now that cannot be contained without a nation-wide lockdown, and adoption of a mitigation policy in response to it is expected to incur additional deaths (relative to a lockdown policy) equal to 28% of those incurred if a mitigation policy had been adopted in March 2020, because the period from now till the end of 2021 is 28% of the time period from March 2020 till the end of 2021. Since the additional deaths under the latter scenario (mitigation from March 2020) have been estimated at up to 40,000, the additional deaths under the former scenario (mitigation from the present time) are estimated at 28% of this, i.e., up to 11,000. The QALY losses from these additional deaths will be (as before) four times the number of deaths. In addition, suppose the medical costs for sufferers ($9.6b above) and GDP losses from those absent from work ($6.8b above) are scaled down in the same proportion as the deaths, to $2.7b and $1.9b respectively. Finally, suppose that GDP losses from this future lockdown will be 50% of the March 2020 lockdown, i.e., $88b. With no allowance for the effects of unemployment, the cost per QALY saved through a lockdown rather than mitigation follows Eq. (7) and would then be at least $1.9 m as follows:

This is double the result in Eq. (7), and therefore favours a mitigation policy for future outbreaks even more strongly than in March 2020. If vaccinations to date, those to come over the time until mass vaccination is completed, and the policy and medical lessons learned since March 2020 reduce the death toll by a further 50%, the denominator in (9) falls by that proportion, raising the ratio to $3.8 m, thereby favouring mitigation even more strongly.

By contrast, if an outbreak could be contained through locking down only part of the country (local lockdown), the GDP losses from doing so would be only some fraction (P) of the $88b in Eq. (9) whilst all other terms would be unchanged (because locking down any part of the country to prevent an outbreak that would otherwise spread to the entire country would warrant the same values for these other terms as for a nationwide lockdown). The cost per QALY saved by the local lockdown would then be as follows:

Thus, if P = 0.10, this cost would be $95,000, which is below the threshold of $100,000. So, the local lockdown would then be justified. In fact, the local lockdown would be justified for any value of P up to 0.10, i.e., a lockdown affecting a part of the country generating up to 10% of GDP would be warranted.

This analysis assumes that, if a lockdown occurs at some future point, only one such lockdown will be required before mass vaccination of the high-risk groups occurs. If more than one may be required, then the GDP loss of P$88b in the last equation would be increased. For example, if there were a 50% probability of a second lockdown affecting the same proportion of the country, the last equation would become

The lockdown policy would only then be justified if P were less than 0.07. Alternatively, if there were a 25% probability of a second lockdown affecting the entire country, the last equation would become

The lockdown policy would not then be justified for any value for P. All of this demonstrates that locking down only part of the country to contain an outbreak might seem justified, but much less so if one allows for the possibility of future outbreaks.

Conclusions

This paper has conducted a cost–benefit analysis (otherwise called a cost-effectiveness analysis) of Australia’s Covid-19 lockdown strategy relative to pursuit of a mitigation strategy in March 2020. The estimated additional deaths from a mitigation policy are 11,500 to 40,000. The result is that the cost per Quality Adjusted Life Year saved by locking down is estimated to be at least 11 times the generally employed figure of $100,000 for health interventions in Australia. The lockdowns were therefore not justified by the standard methodology. Consideration of the information available to the Australian government in March 2020 yields a similar ratio and therefore strongly supported adoption of a mitigation strategy at that time. If Australia experiences a new outbreak, and cannot contain it without resort to a nationwide lockdown, the death toll from adopting a mitigation strategy at this point would be even less than had it done so in March 2020 due to the vaccination campaign, lessons learned since March 2020, and because the period over which the virus would then inflict casualties would now be much less than the period from March 2020. This would favour a mitigation policy even more strongly than in March 2020. This approach of assessing the savings in quality adjusted life years and comparing them to a standard benchmark figure ensures that all quality adjusted life years saved by various health interventions are treated equally, which accords with the ethical principle of equity across people.

Table 4

Expected death rates under various scenarios

	S = 50	S = 100
Country A	2000	300
Country B	250	125

Table 5

Average death rates under various scenarios

	S = 50	S = 100
Country A	600	300
Country B	250	125

Table 6

Stringency levels and death rates

Dep Var (DV)	S10	S20	S30	Sm	Sm	Sm	D	D	D
Indep Var (IV)	D10	D20	D30	D10	D20	D30	D10	D20	D30
Mean DV value	68	77	79	81	81	81	198	198	198
Mean IV value	3	17	50	3	17	50	3	17	50
Coeff on DV	1.9	− 0.07	0.002	− 0.57	− 0.10	− 0.02	7.8	7.4	2.8
P Value for DV	0.09	0.59	0.96	0.37	0.37	0.52	0.53	0	0
Adjusted R^2	0.06	− 0.02	− 0.03	− 0.01	− 0.01	− 0.02	− 0.02	0.40	0.66